BioAI Health Announces the Appointment of Martin Baatz, PhD, as Chief Operating Officer

Veteran digital biomarker executive joins emerging company in precision medicine to further enterprise go-to market success. MANCHESTER, N.H., Feb. 28, 2023 /PRNewswire/ -- BioAI Health, an emerging leader in the…

Continue ReadingBioAI Health Announces the Appointment of Martin Baatz, PhD, as Chief Operating Officer

Development of an AI-powered Prediction of BRAF Mutation & Patient Response to Immunotherapy from Digital Pathology H&E Slides in Metastatic Melanoma

The goal of this webinar is to introduce the Bio-AI Health Predict X platform and demonstrate the feasibility of using H&E slides for the detection of molecular markers as well…

Continue ReadingDevelopment of an AI-powered Prediction of BRAF Mutation & Patient Response to Immunotherapy from Digital Pathology H&E Slides in Metastatic Melanoma